Secondary outcomes also favored Cerebrolysin: NIH Stroke Scale improvement (d=0.74), Barthel Index gains (d=0.56), and a positive trend in modified Rankin Scale scores (d=0.43).
← all excerpts
ABSTRACT NUMBER: ESOC2026A102 META-ANALYSIS: THE EFFECT OF CEREBROLYSIN COMBINED WITH SPEECH THERAPY ON NONFLUENT APHASIA RECOVERY AFTER ISCHEMIC STROKE
1
—
—